Try
Bioventus Inc.
BVSUnited States
44 filed reports · 453 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
44 reports · Apr 2021 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 110 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 23 | 114 | Apr 2021 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 16 | 3,150 | Jul 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 5 | 3,062 | Dec 2021 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 27, 2026 | Aug 5, 2026 | 6 | Open |
| FY2026 Q2 | 10-Q | Jun 27, 2026 | Aug 5, 2026 | 373 | Open |
| FY2026 Q1 | 8-K | Mar 28, 2026 | May 6, 2026 | 4 | Open |
| FY2026 Q1 | 10-Q | Mar 28, 2026 | May 6, 2026 | 235 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Mar 5, 2026 | 8 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 5, 2026 | 1,130 | Open |
| FY2025 Q3 | 10-Q | Sep 27, 2025 | Nov 4, 2025 | 250 | Open |
| FY2025 Q3 | 8-K | Sep 27, 2025 | Nov 4, 2025 | 4 | Open |
| FY2025 Q2 | 8-K | Jun 28, 2025 | Aug 6, 2025 | 4 | Open |
| FY2025 Q2 | 10-Q | Jun 28, 2025 | Aug 6, 2025 | 157 | Open |
| FY2025 Q1 | 10-Q | Mar 29, 2025 | May 6, 2025 | 153 | Open |
| FY2025 Q1 | 8-K | Mar 29, 2025 | May 6, 2025 | 6 | Open |
Financial data
453 concepts · 6,326 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial439 concepts · 5,835 facts · Dec 2019 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents33 · Dec 2019 to Jun 2026
- Comprehensive income net of tax32 · Dec 2019 to Jun 2026
- Comprehensive income net of tax including portion attributable to noncontrolling interest32 · Dec 2019 to Jun 2026
- Cost of goods and services sold depreciation and amortization32 · Dec 2019 to Jun 2026
- Cost of goods and services sold (US GAAP)32 · Dec 2019 to Jun 2026
- Depreciation and amortization32 · Dec 2019 to Jun 2026
- Gross profit (US GAAP)32 · Dec 2019 to Jun 2026
- Income tax expense benefit32 · Dec 2019 to Jun 2026
- Interest income expense nonoperating net32 · Dec 2019 to Jun 2026
- Net income loss32 · Dec 2019 to Jun 2026
- Nonoperating income expense32 · Dec 2019 to Jun 2026
- Operating income loss32 · Dec 2019 to Jun 2026
- Other comprehensive income loss foreign currency transaction and translation adjustment net of tax32 · Dec 2019 to Jun 2026
- Other nonoperating income expense32 · Dec 2019 to Jun 2026
- Profit loss32 · Dec 2019 to Jun 2026
- Provision for doubtful accounts32 · Dec 2019 to Jun 2026
- Research and development expense32 · Dec 2019 to Jun 2026
- Revenue32 · Dec 2019 to Jun 2026
- Selling general and administrative expense32 · Dec 2019 to Jun 2026
- Capital expenditures incurred but not yet paid31 · Dec 2019 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect31 · Dec 2019 to Jun 2026
- Depreciation depletion and amortization31 · Dec 2019 to Jun 2026
- Effect of exchange rate on cash cash equivalents restricted cash and restricted cash equivalents31 · Dec 2019 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities31 · Dec 2019 to Jun 2026
Product2 concepts · 195 facts · Dec 2019 to Jun 2026
- Revenue190 · Dec 2019 to Jun 2026
- HA Product5 · Dec 2022 to Sep 2023
Guidance6 concepts · 114 facts · Mar 2021 to Aug 2026
- Revenue Guidance46 · Mar 2021 to Aug 2026
- EPS (Diluted) Guidance30 · Aug 2022 to Aug 2026
- Revenue Growth Guidance20 · Mar 2021 to Aug 2026
- Net Income Guidance10 · Mar 2021 to Apr 2022
- Net Income Guidance (Adjusted (non-GAAP))6 · Mar 2021 to Nov 2021
- EPS (Diluted) Growth Guidance2 · Mar 2026
Segment4 concepts · 106 facts · Dec 2019 to Jun 2026
- Operating Segments64 · Dec 2019 to Jun 2026
- Revenue36 · Dec 2022 to Jun 2026
- Goodwill4 · Dec 2020 to Dec 2021
- Goodwill acquired during period2 · Dec 2021
Geography2 concepts · 76 facts · Dec 2019 to Jun 2026
- Revenue64 · Dec 2019 to Jun 2026
- U.S.12 · Dec 2022 to Dec 2024
Segments
377 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service6 members · 195 facts
- Restorative Therapies64 · Dec 2019 to Jun 2026
- Pain Treatments59 · Dec 2019 to Jun 2026
- Surgical Solutions59 · Dec 2019 to Jun 2026
- HA Product5 · Dec 2022 to Sep 2023
- Bone Graft Substitutes4 · Jun 2020 to Oct 2021
- Pain Treatments And Joint Preservation4 · Jun 2020 to Oct 2021
Statement business segments4 members · 106 facts
- International51 · Dec 2019 to Jun 2026
- US51 · Dec 2019 to Jun 2026
- International segment2 · Dec 2020 to Dec 2021
- Ussegment2 · Dec 2020 to Dec 2021
Statement geographical2 members · 76 facts
- Non Us38 · Dec 2019 to Jun 2026
- US38 · Dec 2019 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.